ONCOLOGX
ActiveONCOLOGX has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €420k and a net result of €17k. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 95% of 31662 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
88
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability74▲+4
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity ample (current ratio 17.21 against 11.87 in 2024; short-term debt: 2.9% and cash: 19.1% of total assets), and 2.9% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
97.1%
Return on assets
4%
Age of the figures
12 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-09-2025 was due by 30-04-2026 and was filed on 09-02-2026, 80 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
80 d early
2024
29 d early
2023
71 d early
2022
80 d early
2021
30 d early
2020
on the day
2019
7 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-09-2026 and is due by 30-04-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
22-09-2026 today30-09-2026 close30-04-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€420k▲ 4.3%
2024 · €402k
2018: €227k
2019: €244k
2020: €305k
2021: €342k
2022: €361k
2023: €397k
2024: €402k
2018 → 2025
Total assets
€432k▲ 3.9%
2024 · €416k
2018: €345k
2019: €321k
2020: €372k
2021: €396k
2022: €395k
2023: €431k
2024: €416k
2018 → 2025
Net result
€17k▲ 222%
2024 · €5k
2018: €27k
2019: €17k
2020: €61k
2021: €37k
2022: €99k
2023: €36k
2024: €5k
2018 → 2025
Working capital
€200k▲ 32.9%
2024 · €150k
2018: €144k
2019: €161k
2020: €220k
2021: €96k
2022: €129k
2023: €171k
2024: €150k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€342k-€361k▲ 5.4%€397k▲ 9.9%€402k▲ 1.4%€420k▲ 4.3%
Operating result€65k-€137k▲ 113%€53k▼ 61.3%€7k▼ 87.8%€27k▲ 309%
Net result€37k-€99k▲ 164%€36k▼ 63.6%€5k▼ 84.9%€17k▲ 222%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 309% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €432k
Fixed assets
€220k▼ 12.5%
Current assets
€212k▲ 29.2%
Equity and liabilities €432k
Equity
€420k▲ 4.3%
Debt
€13k▼ 8.5%
The debt ratio falls from 3.3% to 2.9%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€58k▲
2024 · €27k
Cash flow
€49k▲
2024 · €26k
Solvency
97.1%▲
2024 · 96.7%
Current ratio
17.21▲
2024 · 11.87
Quick ratio
17.21▲
2024 · 11.87
Debt / equity
0.03▼
2024 · 0.03
ROE
4.2%▲
2024 · 1.3%
ROA
4.0%▲
2024 · 1.3%
Interest coverage
92.84▲
2024 · 55.09
Debt
€13k▼
2024 · €14k
Debt ≤ 1 year
€12k▼
2024 · €14k
Income taxes
€9k▲
2024 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€416k€432k▲
Fixed assets21/28€252k€220k▼
Tangible fixed assets22/27€252k€220k▼
Land and buildings22€195k€182k▼
Plant, machinery and equipment23€2k€1k▼
Furniture and vehicles24€41k€26k▼
Other tangible fixed assets26€15k€11k▼
Current assets29/58€164k€212k▲
Amounts receivable within one year40/41€3k€8k▲
Trade receivables40€171€7k▲
Other amounts receivable41€3k€317▼
Current investments50/53€91k€104k▲
Cash at bank and in hand54/58€70k€82k▲
Deferred charges and accrued income490/1-€18k
Equity and liabilities
Total equity and liabilities10/49€416k€432k▲
Equity10/15€402k€420k▲
Contributions10/11€6k€6k=
Reserves13€394k€412k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€392k€410k▲
Profit (loss) carried forward14€2k€2k▲
Amounts payable17/49€14k€13k▼
Amounts payable within one year42/48€14k€12k▼
Trade debts44€2k€765▼
Suppliers440/4€2k€765▼
Taxes, remuneration and social security45€4k€5k▲
Taxes450/3€4k€5k▲
Other amounts payable47/48€8k€7k▼
Accrued charges and deferred income492/3€0€335▲
Income statement
Code20242025
Non-recurring operating income76A€5k€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€21k€32k▲
Other operating charges640/8€2k€4k▲
Gross operating margin9900€30k€62k▲
Operating profit (loss)9901€7k€27k▲
Financial income75/76B€2k€711▼
Recurring financial income75€2k€711▼
Financial charges65/66B€497€626▲
Recurring financial charges65€497€626▲
Profit (loss) for the period before taxes9903€8k€27k▲
Income taxes67/77€3k€9k▲
Profit (loss) for the period9904€5k€17k▲
Profit (loss) for the period to be appropriated9905€5k€17k▲
Appropriation of the result
Profit (loss) to be appropriated9906€7k€19k▲
Profit (loss) brought forward from the previous period14P€2k€2k▲
Transfer to equity691/2€5k€17k▲
To other reserves6921€5k€17k▲
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
09-02
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
01-04
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-09
Financial
Weakest financial yearnet €5k ▼84.9%
Net result drops to €5k, the lowest in the series; recovery starts the following year.
19-02
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
09-02
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-09
Financial
Highest result since 2018net €99k ▲164%
Operating result €137k, net result €99k, both a record.
31-03
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
30-04
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
23-04
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
27-02
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-04
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
30-03
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Wuustwezel · 1 establishment unit since 2004
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Arthur Boelstraat 662990 WuustwezelGround area
892 m²
Building footprint
128 m²
Volume, LiDAR
833 m³
Parcel 11682G0479/00B002, Flanders · tallest building 9.6 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
OncologX
since 20042.135.892.884
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11682G0479/00B002 | Flanders | 892 m² | 1 · 128 m² | 9.6 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ZOLYER CONSULTING
BE 0644.679.717
Puurs-Sint-Amands · Eq €420k
CoopHub.EU
BE 0758.946.905
Arlon · Eq €420k
E.S.M. ENGINEERING
BE 0859.675.168
Herentals · Eq €419k
SECMAER
BE 0897.030.759
Zaventem · Eq €419k
Waaiberg
BE 0751.551.347
Nijlen · Eq €419k
Of 82,569 companies in sector 70200 we hold annual accounts for 52,573. 36,017 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-01-2004
Fiscal year end30-09
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
74142
Sources
Crossroads Bank for EnterprisesNational Bank · 22 filingsAddress and cadastre registers
Data from official sources, last processed on 22-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryPhone:03/633.05.29